Russian lung cancer care under the microscope: no new drugs, just data

NCT ID NCT06245837

Ongoing Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

First seen Mar 04, 2026 · Last updated May 18, 2026 · Updated 12 times

Summary

This study watches how doctors in Russia treat advanced lung cancer in about 1500 patients. It does not test any new medicine or procedure. Instead, researchers collect information on which treatments are used and how often genetic tests are done. The goal is to understand real-world care patterns, not to change them.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

Research Site

Arkhangelsk, Russia
Research Site

Barnaul, Russia
Research Site

Irkutsk, Russia
Research Site

Kemerovo, Russia
Research Site

Kostroma, Russia
Research Site

Krasnoyarsk, Russia
Research Site

Moscow, Russia
Research Site

Novokuznetsk, Russia
Research Site

Novosibirsk, Russia
Research Site

Obninsk, Russia
Research Site

Perm, Russia
Research Site

Saint Petersburg, Russia
Research Site

Ufa, Russia
Research Site

Vladivostok, Russia
Research Site

Yaroslavl, Russia
Research Site

Yekaterinburg, Russia

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER NON-SMALL CELL LUNG CANCER